Prognostic Value of Pretreatment Serum Transthyretin Level in Patients with Gastrointestinal Cancers
Background. Many studies have shown the link between the pretreatment serum transthyretin and prognosis in gastrointestinal (GI) cancers. However, based on the conclusion, the initial findings were inconsistent. Hence, this meta-analysis was performed to identify the prognostic values of the pretrea...
Main Authors: | Hongliang Luo, Jun Huang, Zhengming Zhu, Peiqian Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2019/7142065 |
Similar Items
-
Prognostic and Clinicopathological Significance of PD-L1 Expression for Colorectal Cancer: A Meta-analysis
by: RAO Xionghui, et al.
Published: (2019-11-01) -
Gastrointestinal disturbances in hereditary transthyretin amyloidosis
by: Wixner, Jonas
Published: (2014) -
The prognostic significance of pretreatment serum CEA levels in gastric cancer: a meta-analysis including 14651 patients.
by: Kai Deng, et al.
Published: (2015-01-01) -
Prognostic value of pretreatment serum carbohydrate antigen 19-9 level in patients with colorectal cancer: A meta-analysis.
by: Zhan Yu, et al.
Published: (2017-01-01) -
A New Serum Biomarker for Lung Cancer - Transthyretin
by: Liyun LIU, et al.
Published: (2009-04-01)